Indication
Megace ES (megestrol acetate) is a concentrated suspension indicated for the treatment of anorexia (loss of appetite),
cachexia (severe malnutrition), or an unexplained, significant weight loss in people with a diagnosis of AIDS.¹

Megace ES is available by Prescription Only. For full Prescribing Information, click here.

*Adverse events greater than placebo derived from the comprehensive adverse events table (≥5%) in Megace ES and megestrol acetate oral suspension prescribing information.

NanoCrystal^® is a registered trade mark of Elan Pharma International Limited, Ireland.
© 2009 PAR Pharmaceutical, Inc. All rights reserved. Par licensed the Megace^® name from Bristol-Myers Squibb Company.